In December 2024, the National Comprehensive Cancer Network® (NCCN) added AUCATZYL (obecabtagene autoleucel) to its Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the treatment of ...

U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and ...

Erythropoiesis is the process by which red blood cells (erythrocytes) are produced. During human foetal development, erythropoiesis first occurs in the yolk sac, then in the foetal liver and then ...